An Integrative Analysis Framework for Identifying the Prognostic Markers from Multidimensional RNA Data of Clear Cell Renal Cell Carcinoma

被引:1
作者
Wang, Peng-Ying [1 ]
Yang, Shihui [1 ]
Bao, Yun-Juan [1 ]
机构
[1] Hubei Univ, Hubei Collaborat Innovat Ctr Green Transformat Bi, Sch Life Sci, State Key Lab Biocatalysis & Enzyme Engn, Wuhan, Peoples R China
关键词
LONG NONCODING RNA; TUMOR-SUPPRESSOR; POOR-PROGNOSIS; BREAST-CANCER; UP-REGULATION; COLON-CANCER; EXPRESSION; MIR-592; PROLIFERATION; PROGRESSION;
D O I
10.1016/j.ajpath.2021.12.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The altered regulatory status of long noncoding RNA (lncRNA), miRNA, and mRNA and their interactions play critical roles in tumor proliferation, metastasis, and progression, which ultimately influence cancer prognosis. However, there are limited studies of comprehensive identification of prognostic biomarkers from combined data sets of the three RNA types in the highly metastatic clear cell renal cell carcinoma (ccRCC). The current study employed an integrative analysis framework of functional genomics approaches and machine learning methods to the lncRNA, miRNA, and mRNA data and identified 16 RNAs (3 lncRNAs, 6 miRNAs, and 7 mRNAs) of prognostic value, with 9 of them novel. A 16 RNA-based score was established for prognosis prediction of ccRCC with significance (P < 0.0001). The area under the curve for the score model was 0.868 to 0.870 in the training cohort and 0.714 to 0.778 in the validation cohort. Construction of the lncRNA-miRNA-mRNA interaction network showed that the downstream mRNAs and upstream lncRNAs in the network initiated from the miRNA or lncRNA markers exhibit significant enrichment in functional classifications associated with cancer metastasis, proliferation, progression, or prognosis. The functional analysis provided clear support for the role of the RNA biomarkers in predicting cancer prognosis. This study provides promising biomarkers for predicting prognosis of ccRCC using multidimensional RNA data, and these findings are expected to facilitate potential clinical applications of the biomarkers.
引用
收藏
页码:671 / 686
页数:16
相关论文
共 105 条
[1]   The role of the complement system in cancer [J].
Afshar-Kharghan, Vahid .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (03) :780-789
[2]   AGEs, RAGEs and s-RAGE; friend or foe for cancer [J].
Ahmad, Saheem ;
Khan, Hamda ;
Siddiqui, Zeba ;
Khan, Mohd Yasir ;
Rehman, Shahnawaz ;
Shahab, Uzma ;
Godovikova, Tatyana ;
Silnikov, Vladimir ;
Moinuddin .
SEMINARS IN CANCER BIOLOGY, 2018, 49 :44-55
[3]   Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer [J].
Amorim, Maria ;
Lobo, Joao ;
Fontes-Sousa, Mario ;
Estevao-Pereira, Helena ;
Salta, Sofia ;
Lopes, Paula ;
Coimbra, Nuno ;
Antunes, Luis ;
de Souse, Susana Palma ;
Henrique, Rui ;
Jeronimo, Carmen .
FRONTIERS IN GENETICS, 2019, 10
[4]   A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression [J].
Anastas, J. N. ;
Biechele, T. L. ;
Robitaille, M. ;
Muster, J. ;
Allison, K. H. ;
Angers, S. ;
Moon, R. T. .
ONCOGENE, 2012, 31 (32) :3696-3708
[5]   OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs [J].
Anaya, Jordan .
PEERJ COMPUTER SCIENCE, 2016,
[6]   Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression [J].
Asl, Elmira Roshani ;
Amini, Mohammad ;
Najafi, Souzan ;
Mansoori, Behzad ;
Mokhtarzadeh, Ahad ;
Mohammadi, Ali ;
Lotfinejad, Parisa ;
Bagheri, Mehdi ;
Shirjang, Solmaz ;
Lotfi, Ziba ;
Rasmi, Yousef ;
Baradaran, Behzad .
LIFE SCIENCES, 2021, 278
[7]   Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma [J].
Bai, Shuheng ;
Wu, YinYing ;
Yan, Yanli ;
Shao, Shuai ;
Zhang, Jiangzhou ;
Liu, Jiaxin ;
Hui, Beina ;
Liu, Rui ;
Ma, Hailin ;
Zhang, Xiaozhi ;
Ren, Juan .
SCIENTIFIC REPORTS, 2020, 10 (01)
[8]   A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer [J].
Bai, Xue ;
Lu, Donglan ;
Lin, Yan ;
Lv, Yufeng ;
He, Liusheng .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (03) :1601-1608
[9]   The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics [J].
Bautista-Sanchez, Diana ;
Arriaga-Canon, Cristian ;
Pedroza-Torres, Abraham ;
De La Rosa-Velazquez, Inti Alberto ;
Gonzalez-Barrios, Rodrigo ;
Contreras-Espinosa, Laura ;
Montiel-Manriquez, Rogelio ;
Castro-Hernandez, Clementina ;
Fragoso-Ontiveros, Veronica ;
Maria Alvarez-Gomez, Rosa ;
Herrera, Luis A. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 20 :409-420
[10]   Long Noncoding RNA and Cancer: A New Paradigm [J].
Bhan, Arunoday ;
Soleimani, Milad ;
Mandal, Subhrangsu S. .
CANCER RESEARCH, 2017, 77 (15) :3965-3981